Global Biopharma CEO/Top Executives Virtual Press Briefing – 30 April 2020 (Video) Published on: 30 April 2020 Resources News Releases Pharma partners in efforts to give coronavirus vaccine for everyone Publications IFPMA Policy Principles on COVID-19 Vaccines Initiative Videos Global Biopharma CEO/Top Executives COVID-19 Media Briefing – 28 May 2020 (Video) Publications COVID-19 Biopharmaceutical Industry – Regulatory Guiding Principles (May 2020) Publications Ethical Considerations for Resuming In-Person Interactions with Healthcare Professionals Post COVID-19: A Guidance Document Videos IFPMA President David Ricks on Global Pledge Committing to Work Together to Beat COVID-19 (Video) News Releases Pharma Joins Global Pledge Committing to Work Together to Beat COVID-19 News Releases Global Pharma update on unprecedented efforts to collaborate in speeding up the search for safe and effective COVID-19 therapies Statements IFPMA Statement on the launch of a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools Videos Pharma CEO/Top Executives Global Response to COVID-19 – Virtual Press Briefing – 19 March 2020 (Video) News Releases Pharma industry body joins as founding partner a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools Statements Global Biopharmaceutical Industry Commitment to Address Coronavirus Public Health Crisis Related Blog Entries 5 Questions to …. five leading biopharmaceutical company CEOs and top executives on the COVID-19 Pandemic Interview – BBC World Newshour – Biopharmaceutical industry commitments on COVID-19 Supporting the global collaboration initiative to accelerate the development, production and equitable access to new COVID-19 tools Related Links Novel coronavirus (COVID-19) Novel coronavirus 2019-nCoV exposes a flaw in the Nagoya Protocol Access to COVID-19 Tools (act) Accelerator Related Topics COVID-19 Tags Epidemicsglobal health securityNovel Coronavirus (COVID-19)pandemicsVaccines